Abstract
The measurement of glycaemic variation (GV) is conceived to be of clinical significance in determining diabetes outcomes. The debate as to the importance of GV has been complicated by studies using various meetrics of GV in qualitatively different datasets. The purpose of this review is to discuss the properties of 8 of the more commonly used metrics (M-value, MAGE, “J”-index, CONGA, BG rate of change, ADRR, Lability/HYPO score and GRADE). Comparable metrics that can be used to measure continuous glycaemic measurements (CGM) (SDBGL, “J”-index, MAGE, CONGA, GRADE) were then compared in assessing diabetic and non-diabetic datasets. In non-diabetic conditions there was very close correlation (correlation coefficients > 0.92) between SDBGL, MAGE and CONGA, however under diabetic conditions the correlation coefficients of the GV metrics diminished significantly. The varying GV metrics have varying inherent properties depending upon the purpose for which they were designed and should not be seen as being interchangeable. Investigators therefore need to be clear about the nature of their enquiry of GV and choose an appropriate metric.
Keywords: Glycaemic variation, Measurement, Comparison
Current Diabetes Reviews
Title: Measuring Glycaemic Variation
Volume: 6 Issue: 1
Author(s): Fergus J. Cameron, Susan M. Donath and Peter A. Baghurst
Affiliation:
Keywords: Glycaemic variation, Measurement, Comparison
Abstract: The measurement of glycaemic variation (GV) is conceived to be of clinical significance in determining diabetes outcomes. The debate as to the importance of GV has been complicated by studies using various meetrics of GV in qualitatively different datasets. The purpose of this review is to discuss the properties of 8 of the more commonly used metrics (M-value, MAGE, “J”-index, CONGA, BG rate of change, ADRR, Lability/HYPO score and GRADE). Comparable metrics that can be used to measure continuous glycaemic measurements (CGM) (SDBGL, “J”-index, MAGE, CONGA, GRADE) were then compared in assessing diabetic and non-diabetic datasets. In non-diabetic conditions there was very close correlation (correlation coefficients > 0.92) between SDBGL, MAGE and CONGA, however under diabetic conditions the correlation coefficients of the GV metrics diminished significantly. The varying GV metrics have varying inherent properties depending upon the purpose for which they were designed and should not be seen as being interchangeable. Investigators therefore need to be clear about the nature of their enquiry of GV and choose an appropriate metric.
Export Options
About this article
Cite this article as:
Cameron J. Fergus, Donath M. Susan and Baghurst A. Peter, Measuring Glycaemic Variation, Current Diabetes Reviews 2010; 6 (1) . https://dx.doi.org/10.2174/157339910790442592
DOI https://dx.doi.org/10.2174/157339910790442592 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in the Synthesis and Development of Curcumin, its Combinations and Formulations and Curcumin-like Compounds as Anti-infective Agents
Current Medicinal Chemistry Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease
Current Neuropharmacology MicroRNAs: Biomarkers for Cardiovascular Disease in Patients with Diabetes Mellitus
Current Topics in Medicinal Chemistry Targeting the Nogo-A Signalling Pathway to Promote Recovery Following Acute CNS Injury
Current Pharmaceutical Design Genetics of Alzheimer's Disease and Frontotemporal Dementia
Current Molecular Medicine Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Therapeutic Interventions in the Glyc(oxid)ation Pathway
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Ligand-Protein Docking: Cancer Research at the Interface between Biology and Chemistry
Current Medicinal Chemistry Targeting Abnormal Nrf2/HO-1 Signaling in Amyotrophic Lateral Sclerosis: Current Insights on Drug Targets and Influences on Neurological Disorders
Current Molecular Medicine Communication from Tubular Epithelial Cells to Podocytes through Sirt1 and Nicotinic Acid Metabolism
Current Hypertension Reviews Metabolic Control of Type 2 Diabetes by Targeting the GLUT4 Glucose Transporter: Intervention Approaches
Current Pharmaceutical Design Targeting Regulatory T Cells in the Treatment of Type 1 Diabetes Mellitus
Current Molecular Medicine VEGF Signaling Regulates Cofilin and the Arp2/3-complex within the Axonal Growth Cone
Current Neurovascular Research Can Environmentally Relevant Levels of Aluminium Promote the Onset and Progression of Neurodegenerative Diseases?
Current Inorganic Chemistry (Discontinued) Exercise and Postprandial Glycemic Control in Type 2 Diabetes
Current Diabetes Reviews Personalized Drug Discovery: HCA Approach Optimized for Rare Diseases at Tel Aviv University
Combinatorial Chemistry & High Throughput Screening Novel Targets in Multiple Sclerosis: To Oxidative Stress and Beyond
Current Topics in Medicinal Chemistry The Role of the Endoplasmic Reticulum in the Accumulation of β-Amyloid Peptide in Alzheimers Disease
Current Molecular Medicine Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?
Current Neuropharmacology Effects of Therapeutic Hypothermia on the Glial Proteome and Phenotype
Current Protein & Peptide Science